{"schema_version":"secwatch.filing_event.v1","accession":"0000883984-21-000031","form_type":"8-K","ticker":"ICUI","cik":"0000883984","company_name":"ICU MEDICAL INC/DE","filed_at":"2021-11-03T23:59:59+00:00","discovered_at":"2026-05-14T18:04:15.985950+00:00","generated_at":"2026-06-28T14:44:58.445668+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"ICU Medical Q3 revenue $336.1M (+5.5% YoY); adj. EPS $2.07 vs $1.90","bullets":["Revenue $336.1M, up from $318.6M in Q3 2020.","GAAP net income $31.1M ($1.43 diluted) vs $25.0M ($1.16) YoY.","Adjusted diluted EPS $2.07 vs $1.90 in prior-year quarter.","Adjusted EBITDA $71.9M, compared to $62.2M in Q3 2020.","GAAP gross margin improved to 38% from 36% YoY."],"urls":{"canonical":"https://secwatch.observer/filing/0000883984-21-000031","json":"https://secwatch.observer/filing/0000883984-21-000031.json","markdown":"https://secwatch.observer/filing/0000883984-21-000031.md","text":"https://secwatch.observer/filing/0000883984-21-000031.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/883984/000088398421000031/0000883984-21-000031-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/883984/000088398421000031/icui-20211103.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T14:44:58.445668+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}